Silk Road Medical Inc (SILK) concluded trading on Thursday at a closing price of $27.11, with 5.07 million shares of worth about $137.43 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 68.39% during that period and on August 08, 2024 the price saw a gain of about 0.18%. Currently the company’s common shares owned by public are about 39.17M shares, out of which, 36.80M shares are available for trading.
Stock saw a price change of 0.22% in past 5 days and over the past one month there was a price change of 0.22%. Year-to-date (YTD), SILK shares are showing a performance of 120.95% which increased to 34.94% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $6.08 but also hit the highest price of $27.19 during that period. The average intraday trading volume for Silk Road Medical Inc shares is 1.68 million. The stock is currently trading 0.21% above its 20-day simple moving average (SMA20), while that difference is up 6.96% for SMA50 and it goes to 57.40% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Silk Road Medical Inc (NASDAQ: SILK) currently have 39.17M outstanding shares and institutions hold larger chunk of about 84.12% of that.
The stock has a current market capitalization of $1.10B and its 3Y-monthly beta is at 1.49. It has posted earnings per share of -$1.44 in the same period. It has Quick Ratio of 6.69 while making debt-to-equity ratio of 0.55. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SILK, volatility over the week remained 0.71% while standing at 0.42% over the month.
Stock’s fiscal year EPS is expected to rise by 3.54% while it is estimated to increase by 5.76% in next year. EPS is likely to grow at an annualized rate of 1.60% for next 5-years, compared to annual growth of -3.21% made by the stock over the past 5-years.
Coverage by Argus stated Silk Road Medical Inc (SILK) stock as a Buy in their note to investors on March 07, 2024, suggesting a price target of $24 for the stock. On January 19, 2024, Stifel Upgrade their recommendations, while on January 03, 2024, Lake Street Initiated their ratings for the stock with a price target of $20. Stock get a Peer perform rating from Wolfe Research on October 24, 2023.
